TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments
  • Shareholders Foundation monitors Class Action Investigations, Cases, and Class Action Settlements.
    Learn More >>>
  • Create Notifications and monitor one Case or multiple Cases. Or submit your entire portfolio! Learn More >>>

REGENXBIO Inc. (NASDAQ: RGNX) Investor Securities Class Action Lawsuit 02/13/2026

  • If you purchased a significant amount of shares of REGENXBIO Inc. (NASDAQ: RGNX) between February 9, 2022 and January 27, 2026, and / or if you purchased any NASDAQ: RGNX shares prior to February 2022 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: April 14, 2026 February 9, 2022 and January 27, 2026. NASDAQ: RGNX investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

February 13, 2026 - An investor in shares of REGENXBIO Inc. (NASDAQ: RGNX) filed a lawsuit in the U.S. District Court for the District of Maryland over alleged violations of Federal Securities Laws by REGENXBIO Inc. in connection with certain allegedly false and misleading statements made between February 9, 2022 and January 27, 2026.   Rockville, MD based REGENXBIO Inc., a clinical-s...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)